Using your inhaler

Please review the About RELENZA section for important information about the effects of RELENZA including the section "Important Safety Information About RELENZA" for information about the risk of breathing difficulties.

If RELENZA is prescribed for a child, dosing should be supervised by an adult who understands how to use RELENZA and has been instructed in its use by a healthcare provider.

Learn more about your DISKHALER


Step A: Load the medicine into the DISKHALER


Step B: Puncture the blister

Keep DISKHALER Level for Steps B and C

Step C: Inhale

Step D: Move the medicine disk to the next blister
for the next inhalation
Important Instructions

•	Read your entire leaflet before using RELENZA. Even if you have had a previous prescription for RELENZA, read the leaflet to see if any information has changed.
•	The usual dose is 2 inhalations. However, you must take the number of inhalations your healthcare provider has prescribed.
•	If you feel worse or develop new symptoms during or after treatment, or if your flu symptoms do not start to improve, stop using the medicine and contact your healthcare provider.
•	Keep out of reach of children.
•	Always check inside the mouthpiece to make sure it is clear before each use. If foreign objects are in the mouthpiece, they could be inhaled and cause serious harm.
•	Always replace the cover after each use.
•	Throw away the DISKHALER after treatment is completed.
•	This DISKHALER is for use only with RELENZA. Do not use the RELENZA DISKHALER device with FLOVENT® (fluticasone propionate) and do not use RELENZA with the FLOVENT DISKHALER device.

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).

REMEMBER: This medicine has been prescribed for you by your healthcare provider. DO NOT give this medicine to anyone else.

Important Safety Information

Some patients have had bronchospasm (wheezing) or serious breathing problems when they used RELENZA. Many but not all of these patients had previous asthma or chronic obstructive pulmonary disease. RELENZA has not been shown to shorten the duration of influenza in people with these diseases. Because of the risk of side effects and because it has not been shown to help them, RELENZA is not recommended for people with chronic respiratory disease such as asthma or chronic obstructive pulmonary disease.

If you develop worsening respiratory symptoms such as wheezing or shortness of breath, stop using RELENZA and contact your healthcare provider right away.

If you have chronic respiratory disease such as asthma and chronic obstructive pulmonary disease and your healthcare provider has prescribed RELENZA, you should have a fast-acting, inhaled bronchodilator available for your use. If you are scheduled to use an inhaled bronchodilator at the same time as RELENZA, use the inhaled bronchodilator before using RELENZA.

Other kinds of infections can appear like influenza or occur along with influenza, and need different kinds of treatment. Contact your healthcare provider if you feel worse or develop new symptoms during or after treatment, or if your influenza symptoms do not start to get better.

In studies, the most common side effects with RELENZA have been headaches; diarrhea; nausea; vomiting; nasal irritation; bronchitis; cough; sinusitis; ear, nose, and throat infections; and dizziness. Other side effects that have been reported, but were not as common, include rashes and allergic reactions, some of which were severe.

This list of side effects is not complete. Your healthcare provider or pharmacist can discuss with you a more complete list of possible side effects with RELENZA. Talk to your healthcare provider promptly about any side effects you have.